Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • nppa

    Tag: nppa

    You Searched For "nppa"
    Covid-19 Impact: NPPA asks drugmakers to submit availablility data of 58 APIs, details

    Covid-19 Impact: NPPA asks drugmakers to submit availablility data of 58 APIs, details

    Medical Dialogues Bureau28 Feb 2020 10:56 AM GMT
    New Delhi: In the light of coronavirus outbreak worldwide, the apex drug regulator National Pharmaceutical Pricing Authority (NPPA) has identified 58...
    NPPA fixes price of 17 formulations including BP drugs,painkillers; details

    NPPA fixes price of 17 formulations including BP drugs,painkillers; details

    Medical Dialogues Bureau31 Jan 2020 11:19 AM GMT
    New Delhi : Through a recent notice, the National Pharmaceutical Pricing Authority,Ministry of Chemicals and Fertilizers,Government of India has fixed...
    Sun Pharma plea to refix price of Ciprofloxacin Hydrochloride Injection rejected

    Sun Pharma plea to refix price of Ciprofloxacin Hydrochloride Injection rejected

    Farhat Nasim6 Jan 2020 7:45 AM GMT
    New Delhi: In a major setback to Ranbaxy Laboratories Limited (now Sun Pharmaceutical Industries Ltd.), the Department of Pharmaceuticals (DoP) has...
    Minister informs Parliament about steps taken to promote affordable generic drugs

    Minister informs Parliament about steps taken to promote affordable generic drugs

    Medical Dialogues Bureau26 Nov 2019 11:00 AM GMT
    New Delhi: The Minister in the Ministry of Chemicals and Fertilizers D V Sadananda Gowda recently informed the Parliament about the steps taken by the...
    With questions about safety of Merils Made in India BVS stent, NPPA defers its appeal for price exemption

    With questions about safety of Meril's Made in India BVS stent, NPPA defers its appeal for price exemption

    Medical Dialogues Bureau21 Nov 2019 6:39 AM GMT
    New Delhi: With an industry association raising health and safety concerns about the flagship Sirolimus-Eluting BioResorbable vascular scaffold system...
    NPPA fixes retail price of 12 combo drugs including Aspirin, Atorvastatin, Metformin; Details

    NPPA fixes retail price of 12 combo drugs including Aspirin, Atorvastatin, Metformin; Details

    Farhat Nasim17 Nov 2019 7:38 AM GMT
    New Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
    NPPA fixes retail price of 59 combo drug formulations including Paracetamol, Metformin, Atorvastatin; Details

    NPPA fixes retail price of 59 combo drug formulations including Paracetamol, Metformin, Atorvastatin; Details

    Medical Dialogues Bureau15 Nov 2019 10:59 AM GMT
    New Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
    NPPA fixes retail price of 14 drug formulations; Details

    NPPA fixes retail price of 14 drug formulations; Details

    Farhat Nasim13 Nov 2019 5:53 AM GMT
    New Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
    Medical Devices classified as Drugs: CDSCO releases Amendment Rules for registeration of 36 devices

    Medical Devices classified as Drugs: CDSCO releases Amendment Rules for registeration of 36 devices

    Medical Dialogues Bureau25 Oct 2019 10:59 AM GMT
    New Delhi: Through a recent Gazette Notification, Central Drugs Standard Control Organisation (CDSCO) has recently released Draft Medical Devices...
    Health Ministry to bring all Medical Devices under CDSCO regulations, Invites comments

    Health Ministry to bring all Medical Devices under CDSCO regulations, Invites comments

    Farhat Nasim19 Oct 2019 12:08 PM GMT
    Once finalized, the medical device makers will have to get licences from the Drug Controller General of India (DCGI) while CDSCO will be the nodal...
    Price cap of Orthopaedic Knee Implants led to boosted sales, says NPPA

    Price cap of Orthopaedic Knee Implants led to boosted sales, says NPPA

    Farhat Nasim11 Sep 2019 1:12 PM GMT
    New Delhi: The apex drug price regulator, the National Pharmaceutical Pricing Authority (NPPA) has apprised about the positive impact of capping...
    DOP junks Cipla plea to refix MRP of Tafmune–EM

    DOP junks Cipla plea to refix MRP of Tafmune–EM

    Farhat Nasim2 Sep 2019 11:04 AM GMT
    New Delhi: Through a recent decision, the Department of Pharmaceuticals (DOP) has rejected the review application filed by Cipla Limited against...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier

    This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:

    Search only trustworthy HONcode health websites:

    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

    © 2020 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    X